ArticleVaccines2022

Promising Efficacy of a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients Treated with Anti-CD20 Antibody Who Failed 2-Dose Vaccination.

Yohei Funakoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.